April is Head and Cancer Awareness Month, and the Georgia Cancer Center held free screenings Friday. It’s a process that ...

HPV-related throat cancers are rising, but risks can be lowered by avoiding tobacco, limiting alcohol, getting vaccinated, ...

Laryngeal cancer is a serious condition that can impact your ability to speak, swallow and in some cases, breathe. Each year, ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...

A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

Adding pembrolizumab before and after surgery reduced recurrence and improved response in patients with locally advanced head ...

FDA meeting requested following Phase IIb trial showing median overall survival of 17.6 months without chemotherapy Immutep ...

Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain ...

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

Dr. Mohamad Issa and Dr. Andrew Rosko with ProMedica talk with Amanda about what to look out for when it comes to head and ...

Serenity Health held its 4th annual Fentanyl Awareness Day event on Tuesday, April 29. Janice Thigpen is the first woman ...